Sleep Disorders and Cardiovascular Risk, Senescence and Ageing:

-Investigate the molecular relationships between sleep diseases and the development of cardiovascular problems.

-Identify possible treatments to mitigate the effects of poor sleep on the senescence process.

Early diagnosis of lung cancer:

- Develop new early detection technologies with the aim of improving survival rates in lung cancer patients.

COVID-19, Cardiovascular Risk and Persistent COVID:

-Investigate the mechanisms linking COVID-19 infection with cardiovascular risk. Compare with other respiratory viruses

Understand the persistence of COVID and its long-term effects on cardiovascular health.

Respiratory Diseases and Intestinal Dysbiosis (Lung-Gut Axis):

-Exploring the molecular interactions between the respiratory system and the gut microbiota to better understand dysbiosis and its impact on respiratory diseases.

Pulmonary Hypertension, Pulmonary Embolism and Endothelial Dysfunction:

-Investigate the pathophysiological mechanisms of pulmonary hypertension and pulmonary embolism.

-To develop therapeutic strategies aimed at improving the associated endothelial dysfunction.

Study of Biomarkers in Cardiopulmonary Diseases:

-Identify and validate specific biomarkers for different cardiopulmonary diseases.

-Establish standardised protocols for the clinical use of the identified biomarkers.

2D and 3D Vascular Models, Organ-on-a-Chip and Animal Models:

-Optimise and validate in vitro vascular models for preclinical studies.

-To integrate the different models to obtain a more complete view of the physiopathological processes in cardiopulmonary diseases.